PubMed 26228747Schneider et al.Page 20Prahallad A et al.

PubMed 19878870Schneider et al.Page 21Tian H et al.

PubMed 23582323Schneider et al.Page 22Zhang X et al.

PubMed 22115911Schneider et al.Page 26Sherman MH et al.

PubMed 25837594Schneider et al.Page 27Beyaz S et al.

PubMed 25970248Schneider et al.Page 28Peng W et al.

PubMed 27340177Schneider et al.Page 29Platt RJ et al.

PubMed 26627737Schneider et al.Page 30Schneider et al.Page 31Figure 1.

APC adenomatous polyposis coli ARID1A AT-rich interactive domain 1A ATM ataxia telangiectasia mutated ATR ataxia telangiectasia and Rad3-related BAP1 BRCA1-associated protein 1 CDH1 cadherin 1 CDKN2A cyclin-dependent kinase inhibitor 2A CREBBP CREB-binding protein CTNNB1 encoding b-catenin DMN2 dynamin 2 EGFR epidermal growth factor receptor ESR1 oestrogen receptor 1 EZH2 enhancer of zeste homologue 2 FAT atypical cadherin FBXW7 F-box and WD repeat domain containing 7 GATA3 GATA bindingSchneider et al.Page 33protein 3 GNAS encoding G protein GaS GRIN2A glutamate receptor ionotropic NMDA 2A JAK3 Janus kinase 3 KDM5C lysine-specific demethylase 5C KMT2 histone-lysine N-methyltransferase 2 NCOR1 nuclear receptor co-repressor 1 MYD88 myeloid differentiation primary response 88 NF1 neurofibromatosis type 1 PBRM1 polybromo 1 SETD2 SET domain containing 2 PHF6 PHD finger protein 6 SMARCA4 SWISNF related matrix associated actin-dependent regulator of chromatin subfamily A member 4 SOCS1 suppressor of cytokine signalling 1 SPOP speckle-type POZ protein STK11 serine-threonine kinase 11 TERT telomerase reverse transcriptase TNFAIP3 tumour necrosis factor a TNFa-induced protein 3 TSC2 tuberous sclerosis 2 TRRAP transformationtranscription domain associated protein VHL von Hippel-Lindau tumour suppressor WT1 Wilms tumour 1.Schneider et al.Page 34Figure 3.

Investigation recognition and in- depth biological understanding of these differences will be vital for the design of next-generation clinical trials and the implementation of molecularly-guided cancer therapies in the future.IntroductionIn the past three decades molecular tumour profiling and functional studies have led to the identification and validation of critical genes and pathways which are dysregulated or Dieter Saur.Subject CategoriesURI 631671059602 URI 6316768URI 631671059 URI 63167395 URI 6316770Table of Contents SummaryIn this Opinion article Schneider et al.

